SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Faust Megan (Last) (First) (Middle) 2045 E INNOVATION CIRCLE (Street) TEMPE AZ 85284 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol AMKOR TECHNOLOGY, INC. [ AMKR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) CFO
	3. Date of Earliest Transaction (Month/Day/Year) 11/17/2022
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2022		M		6,000	A	$9.48	14,512	D
Common Stock	11/17/2022		S(1)		6,000	D	$27.31	8,512	D
Common Stock	11/18/2022		M		20,000	A	$9.48	28,512	D
Common Stock	11/18/2022		M		10,000	A	$9.86	38,512	D
Common Stock	11/18/2022		S(1)		30,000	D	$28.95	8,512	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right-to-Buy)	$9.48	11/17/2022		M			6,000	02/15/2020(2)	02/15/2029	Common Stock	6,000	$0.00	82,500	D
Employee Stock Option (Right-to-Buy)	$9.48	11/18/2022		M			20,000	02/15/2020(2)	02/15/2029	Common Stock	20,000	$0.00	62,500	D
Employee Stock Option (Right-to-Buy)	$9.86	11/18/2022		M			10,000	02/27/2018(3)	02/27/2027	Common Stock	10,000	$0.00	0	D

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2022.

2. This stock option (the "2019 Option") to acquire 150,000 shares of the Issuer's common stock (the "2019 Option Shares") was granted on February 15, 2019 (the "2019 Grant Date") and vests over four years as follows: (i) with respect to 25% of the 2019 Option Shares, on the first anniversary of the 2019 Grant Date; and (ii) with respect to the remainder of the 2019 Option Shares, in equal quarterly installments thereafter, such that 100% of the 2019 Option will vest on the fourth anniversary of the 2019 Grant Date.

3. This stock option (the "2017 Option") to acquire 120,000 shares of the Issuer's common stock (the "2017 Option Shares") was granted on February 27, 2017 (the "2017 Grant Date") and vests over four years as follows: (i) with respect to 25% of the 2017 Option Shares, on the first anniversary of the 2017 Grant Date; and (ii) with respect to the remainder of the 2017 Option Shares, in equal quarterly installments thereafter, such that 100% of the 2017 Option will vest on the fourth anniversary of the 2017 Grant Date.

Remarks:

	Mark N. Rogers, Attorney-in-Fact for Megan Faust	11/18/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.